Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 9 - Drugs for disorders of the cardiovascular system
Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484)
09/2005
09/06/2005CA2217479C Derivatives of phenoxyethylamine having a high affinity for 5-ht1a receptor, their preparation procedure, their application as medications and pharmaceutical compounds containing them
09/06/2005CA2086137C Benzofuranylimidazole derivatives, a process for the preparation and therapeutical compositions containing the same
09/03/2005CA2486341A1 Supplement foods and pharmaceuticals
09/01/2005WO2005080568A1 Methods and compositions for treatment or prevention of secondary ischemic injury
09/01/2005WO2005080553A1 Cell-associated physiologically active substance and cell culture supplement
09/01/2005WO2005080385A1 Indanol derivative
09/01/2005WO2005080384A2 Benzimidazole derivative and use as aii receptor antagonist
09/01/2005WO2005080378A1 Fused pyridazine derivatives
09/01/2005WO2005080330A1 Heteroarylphenylurea derivative
09/01/2005WO2005080319A1 Hydrazino alcohol derivatives useful as inhibitors of copper-containing amine oxidases
09/01/2005WO2005079847A1 NUCLEAR TRANSFER PROMOTER FOR Cdc42 PROTEIN AND METHOD OF SCREENING THE SAME
09/01/2005WO2005079846A1 NUCLEAR TRANSFER PROMOTER FOR Rac PROTEIN AND METHOD OF SCREENING THE SAME
09/01/2005WO2005079792A1 Preventive or therapeutic agents for severe diabetic retinopathy
09/01/2005WO2005079783A1 Medicine capable of inhibiting activation of transcription factor klf5
09/01/2005WO2004048512A3 Novel proteins and nucleic acids encoding same
09/01/2005WO2002083873A3 Enzymes
09/01/2005US20050192350 Aspirin-triggered lipoxins as modulators of diseases associated with polymorphoneutrophil inflammation; antiinflammatory agents
09/01/2005US20050192335 Acyloxypyrrolidine derivatives, preparation thereof and application thereof in therapeutic
09/01/2005US20050192334 Condensed indoline derivatives and their use as 5HT, in particular 5HT2C, receptor ligands
09/01/2005US20050192327 Myocardial infarction or its recurrence is treated with telmisartan an ACE inhibitor
09/01/2005US20050192326 Treating stroke or reccurence with an ACE inhibitor selected from quinapril, captropril, lisinopril, perindopril, trandolapril, enalapril, moexipril, fosinopril, ramipril, cilazapril, imidapril, spirapril, temocapril, benazepril, alacepril, ceronapril, delapril, moveltipril and trandolapril
09/01/2005US20050192318 5-[4-Methylsulfonyloxy-2-(S)-(3,4-dichlorophenyl)butyl]-10-cyano-3-(R)-methyl-6-oxo-3,4,5,6-tetrahydro-2H-benzo[b][1,5]oxazocine as antidepressant
09/01/2005US20050192313 Thio substituted with a hetero multiring group; sleepiness, promotion of wakefulness, Parkinson's disease, cerebral ischemia, stroke, sleep apneas, eating disorders, stimulation of appetite and weight gain, attention deficit hyperactivity disorder
09/01/2005US20050192307 Benzimidazolone compounds
09/01/2005US20050192306 Pyrimidine derivatives as selective inhibitors of COX-2
09/01/2005US20050192304 Rho-kinase inhibitors
09/01/2005US20050192284 Crystal modification of a N-phenyl-2-pyrimidineamine derivative, processed for its manufacture and its use
09/01/2005US20050192259 A sustained release formulation of an aldosterone antagonist orally administered about 6-12 hours prior to the acrophase to provide a profile of plasma drug concentration corresponding to the diurnal cycle of plasma aldosterone concentration; hypotensive agents; circadi rhythm; cardiovascular disorders
09/01/2005US20050192238 Modulation of the expression of genes dependent on stat-1
09/01/2005US20050192235 Compositions and methods for treating or preventing diseases of body passageways
09/01/2005US20050192208 Cardiovascular disorders; antiarrhythmia agents; sodium channel moderators ; potassium channel moderators; prevent fibrillation
09/01/2005US20050191696 Compounds, methods of screening, and in vitro and in vivo uses involving anti-apoptotic genes and anti-apoptotic gene products
09/01/2005US20050191690 Membrane proteins for identifying modulators for prevention and treatment of infection, cell proliferative, neurological, cardiovascular, gastrointestinal, autoimmune/inflammatory and metabolic disorders
09/01/2005US20050191650 Used to reduce body temperature, suppress appetite, and therapy or prophylaxis of congestive heart failure and various stress-related disorders
09/01/2005US20050191348 Neurodegenerative disease, dementia, affective or mood disorder, drug use and dependence, memory loss disorder, acute neurological traumatic disorder or neurotrauma
09/01/2005US20050191301 Mammalian EPO mimetic CH1 deleted mimetibodies, compositions, methods and uses
09/01/2005US20050191300 Immunotherapy of autoimmune disorders using antibodies which target B-cells
09/01/2005US20050191288 Administering to patient before or simultaneously with surgery at least one heparinase enzyme, wherein heparinase enzyme decreases localized inflammatory response in the tissue of the patient
09/01/2005CA2557539A1 Indanol derivative
09/01/2005CA2557392A1 Preventive or therapeutic agents for severe diabetic retinopathy
09/01/2005CA2556805A1 Use of factor xiii for stimulating the perfusion of ischemic tissue
09/01/2005CA2555421A1 Agonists and antagonists of p28 ebi3 and wsx/tccr for treating immune disorders
09/01/2005CA2555133A1 Substituted quinoline compounds
08/2005
08/31/2005EP1568699A1 1,3-dihydroimidazole fused-ring compound
08/31/2005EP1568697A1 1,3-benzothiazinone derivatives, process for producing the same and use thereof
08/31/2005EP1568695A1 3,4-Dihydroquinazoline derivatives as T-type calcium channel blockers and method of preparing the same
08/31/2005EP1568685A1 Aminoadamantane derivatives as therapeutic agents
08/31/2005EP1567528A1 Mixed lineage kinase modulators
08/31/2005EP1567502A1 Substituted dihydrophenanthridinesul fonamides
08/31/2005EP1567487A2 Open chain prolyl urea-related modulators of androgen receptor function
08/31/2005EP1567197A2 Compositions for treating or preventing angiogenesis-dependent symptoms
08/31/2005EP1567186A2 Nogo, caspr, f3 and nb-3 useful in the treatment of injury and disease to the central nervous system
08/31/2005EP1567182A2 Preventing desensitization of receptors
08/31/2005EP1567176A1 An anti-arrhythmic compound from king cobra venom and a process of purification thereof
08/31/2005EP1567160A2 Method of treatment of myocardial infarction
08/31/2005EP1567150A1 Derivatives of indole-3-carboxamide, preparation method thereof and application of same in therapeutics
08/31/2005EP1567141A1 Labeled macrophage scavenger receptor antagonists for imaging cardiovacular diseases
08/31/2005EP1430057B1 Substituted 2-pyridinyl-6,7,8,9-tetrahydropyrimido 1,2-a]pyrimidin-4-one and 7-pyridinyl-2,3-dihydroimidazo 1,2-a]pyrimidin-5(1h)one derivatives
08/31/2005EP1397359B1 1-biaryl-1,8-napthyridin-4-one phosphodiesterase-4 inhibitors
08/31/2005EP1392714B1 Steroids as agonists for fxr
08/31/2005EP1390366B1 The citrate salt of 5,8,14,-triazatetracyclo(10.3.1.02,11.04,9)-hexadeca-2(11),3,5,7,9-pentaene
08/31/2005EP1268445B1 4-amino-5-cyano-2-anilino-pyrimidine derivatives and their use as inhibitors of cell-cycle kinases
08/31/2005EP1240168B1 Bicyclic inhibitors of glycogen synthase kinase 3
08/31/2005EP1169060B1 Sodium channel blocker compositions and the use thereof
08/31/2005EP1163212B1 Amide derivatives
08/31/2005EP1163204B1 Lipoxin compounds and their use
08/31/2005EP1140809B1 New biphenyl and biphenyl-analogous compounds as integrin antagonists
08/31/2005EP1095020B1 2-aminopyridine erivatives, their use as medicines and pharmaceutical compositions containing them
08/31/2005EP1003497B1 Il-8 receptor antagonists
08/31/2005EP0973819B1 Non-antigenic branched polymer conjugates
08/31/2005EP0888333B1 Novel benzothiepines having activity as inhibitors of ileal bile acid transport and taurocholate uptake
08/31/2005EP0882718B1 Benzimidazole derivatives
08/31/2005EP0869813B1 Use of beta-interferons to treat restenosis
08/31/2005CN1662663A DNA enzyme to inhibit plasminogen activator inhibitor-1
08/31/2005CN1662651A Method of diagnosing risk of myocardial infarction
08/31/2005CN1662554A Vaccine for the prevention and treatment of alzheimer's and amyloid related diseases
08/31/2005CN1662549A Glucocorticoid receptor ligands for the treatment of metabolic disorders
08/31/2005CN1662548A Regeneration of endogenous myocardial tissue by induction of neovascularization
08/31/2005CN1662539A [1, 4]diazocino [7, 8, 1-hi]indole derivatives as antipsychotic and antiobesity agents
08/31/2005CN1662537A Pyrazolo (1, 5-a) pyrimidine derivative and nad(p)h oxidase inhibitor containing the same
08/31/2005CN1662534A 1, 2, 3, 4, 7, 8-hexahydro-6h-[1, 4]diazepino[6, 7, 1-1j]quinoline derivatives as antipsychotic and antiobesity agents
08/31/2005CN1662531A Hetero-bicyclic compounds
08/31/2005CN1662524A Indole derivatives useful as histamine h3 antagonists
08/31/2005CN1662519A Heterocyclic compounds as glycine transport inhibitors
08/31/2005CN1662516A N, N-disubstituted diazocycloalkanes
08/31/2005CN1662514A Benzothiadiazepine derivatives, processes for their preparation and pharmaceutical compositions containing them
08/31/2005CN1662509A Pyrrolo-triazine aniline compounds useful as kinase inhibitors
08/31/2005CN1662508A Compounds, compositions and methods
08/31/2005CN1662506A Methods and compositions for treatment of central and peripheral nervous system disorders and novel compounds useful therefor
08/31/2005CN1662505A Quinoline derivatives as caspase-3 inhibitor, preparation for producing the same and pharmaceutical composition comprising the same
08/31/2005CN1662504A 2, 5-disubstituted 3-mercaptopentanoic acid
08/31/2005CN1662498A Novel tetrahydropyridine derivatives as renin inhibitors
08/31/2005CN1662496A Cannabinoid receptor agonists
08/31/2005CN1662495A Acid-group-substituted diphenylazetidinones, process for their preparation, medicaments comprising these compounds, and their use
08/31/2005CN1662494A Cationically substituted diphenylazetidinones, process for their preparation, medicaments comprising these compounds, and their use
08/31/2005CN1662493A Ring -substituted diphenylazetidinones, process for their preparation, medicaments comprising these compounds, and their use
08/31/2005CN1662490A Nitrooxyderivatives of cyclooxygenase-2 inhibitors
08/31/2005CN1662487A Amide linker peroxisome proliferator activated receptor modulators
08/31/2005CN1662257A Combination of PDE5 inhibitors with angiotensin II receptor antagonists
08/31/2005CN1662256A Combination of angiotensin II receptor blocker and beta-blocker for secondary prevention of myocardial infarction
1 ... 759 760 761 762 763 764 765 766 767 768 769 770 771 772 773 774 775 776 777 778 779 ... 1595